0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Inhaler Devices for Respiratory Medicines Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-17I17881
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Inhaler Devices for Respiratory Medicines Market Research Report 2024
BUY CHAPTERS

Global Inhaler Devices for Respiratory Medicines Market Research Report 2024

Code: QYRE-Auto-17I17881
Report
July 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Inhaler Devices for Respiratory Medicines Market

Inhaler devices for respiratory medicines are medical tools designed to deliver medications directly into the lungs, providing relief and treatment for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders. These devices come in various forms, including metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and soft mist inhalers (SMIs), each suited for different types of medication and patient needs. They work by converting liquid or powdered medication into an aerosol or mist that can be easily inhaled, ensuring fast and targeted delivery to the respiratory system. Inhalers are essential for managing respiratory conditions, offering a convenient and effective means of administering medication with minimal systemic side effects.
The global Inhaler Devices for Respiratory Medicines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Inhaler Devices for Respiratory Medicines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Inhaler Devices for Respiratory Medicines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Inhaler Devices for Respiratory Medicines include GlaxoSmithKline (GSK), AstraZeneca, Boehringer Ingelheim, Mylan, Viatris, Novartis, AptarGroup, Chiesi Farmaceutici, Koninklijke Philips, Teva Pharmaceutical Industries, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inhaler Devices for Respiratory Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaler Devices for Respiratory Medicines.
The Inhaler Devices for Respiratory Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Inhaler Devices for Respiratory Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaler Devices for Respiratory Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Inhaler Devices for Respiratory Medicines Market Report

Report Metric Details
Report Name Inhaler Devices for Respiratory Medicines Market
Segment by Type
  • Metered- dose Inhalers
  • Dry-powder Inhalers
  • Nebulizers
Segment by Application
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis (CF)
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline (GSK), AstraZeneca, Boehringer Ingelheim, Mylan, Viatris, Novartis, AptarGroup, Chiesi Farmaceutici, Koninklijke Philips, Teva Pharmaceutical Industries, Monaghan Medical, OMRON, PARI International, Vectura, H&T Presspart
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Inhaler Devices for Respiratory Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Inhaler Devices for Respiratory Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Inhaler Devices for Respiratory Medicines Market report?

Ans: The main players in the Inhaler Devices for Respiratory Medicines Market are GlaxoSmithKline (GSK), AstraZeneca, Boehringer Ingelheim, Mylan, Viatris, Novartis, AptarGroup, Chiesi Farmaceutici, Koninklijke Philips, Teva Pharmaceutical Industries, Monaghan Medical, OMRON, PARI International, Vectura, H&T Presspart

What are the Application segmentation covered in the Inhaler Devices for Respiratory Medicines Market report?

Ans: The Applications covered in the Inhaler Devices for Respiratory Medicines Market report are Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis (CF), Idiopathic Pulmonary Fibrosis (IPF), Others

What are the Type segmentation covered in the Inhaler Devices for Respiratory Medicines Market report?

Ans: The Types covered in the Inhaler Devices for Respiratory Medicines Market report are Metered- dose Inhalers, Dry-powder Inhalers, Nebulizers

1 Inhaler Devices for Respiratory Medicines Market Overview
1.1 Product Definition
1.2 Inhaler Devices for Respiratory Medicines by Type
1.2.1 Global Inhaler Devices for Respiratory Medicines Market Value Comparison by Type (2024-2030)
1.2.2 Metered- dose Inhalers
1.2.3 Dry-powder Inhalers
1.2.4 Nebulizers
1.3 Inhaler Devices for Respiratory Medicines by Application
1.3.1 Global Inhaler Devices for Respiratory Medicines Market Value by Application (2024-2030)
1.3.2 Asthma
1.3.3 Chronic Obstructive Pulmonary Disease (COPD)
1.3.4 Cystic Fibrosis (CF)
1.3.5 Idiopathic Pulmonary Fibrosis (IPF)
1.3.6 Others
1.4 Global Inhaler Devices for Respiratory Medicines Market Size Estimates and Forecasts
1.4.1 Global Inhaler Devices for Respiratory Medicines Revenue 2019-2030
1.4.2 Global Inhaler Devices for Respiratory Medicines Sales 2019-2030
1.4.3 Global Inhaler Devices for Respiratory Medicines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Inhaler Devices for Respiratory Medicines Market Competition by Manufacturers
2.1 Global Inhaler Devices for Respiratory Medicines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Inhaler Devices for Respiratory Medicines Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Inhaler Devices for Respiratory Medicines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhaler Devices for Respiratory Medicines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhaler Devices for Respiratory Medicines, Product Type & Application
2.7 Global Key Manufacturers of Inhaler Devices for Respiratory Medicines, Date of Enter into This Industry
2.8 Global Inhaler Devices for Respiratory Medicines Market Competitive Situation and Trends
2.8.1 Global Inhaler Devices for Respiratory Medicines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inhaler Devices for Respiratory Medicines Players Market Share by Revenue
2.8.3 Global Inhaler Devices for Respiratory Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inhaler Devices for Respiratory Medicines Market Scenario by Region
3.1 Global Inhaler Devices for Respiratory Medicines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Inhaler Devices for Respiratory Medicines Sales by Region: 2019-2030
3.2.1 Global Inhaler Devices for Respiratory Medicines Sales by Region: 2019-2024
3.2.2 Global Inhaler Devices for Respiratory Medicines Sales by Region: 2025-2030
3.3 Global Inhaler Devices for Respiratory Medicines Revenue by Region: 2019-2030
3.3.1 Global Inhaler Devices for Respiratory Medicines Revenue by Region: 2019-2024
3.3.2 Global Inhaler Devices for Respiratory Medicines Revenue by Region: 2025-2030
3.4 North America Inhaler Devices for Respiratory Medicines Market Facts & Figures by Country
3.4.1 North America Inhaler Devices for Respiratory Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Inhaler Devices for Respiratory Medicines Sales by Country (2019-2030)
3.4.3 North America Inhaler Devices for Respiratory Medicines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhaler Devices for Respiratory Medicines Market Facts & Figures by Country
3.5.1 Europe Inhaler Devices for Respiratory Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Inhaler Devices for Respiratory Medicines Sales by Country (2019-2030)
3.5.3 Europe Inhaler Devices for Respiratory Medicines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhaler Devices for Respiratory Medicines Market Facts & Figures by Region
3.6.1 Asia Pacific Inhaler Devices for Respiratory Medicines Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Inhaler Devices for Respiratory Medicines Sales by Region (2019-2030)
3.6.3 Asia Pacific Inhaler Devices for Respiratory Medicines Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Inhaler Devices for Respiratory Medicines Market Facts & Figures by Country
3.7.1 Latin America Inhaler Devices for Respiratory Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Inhaler Devices for Respiratory Medicines Sales by Country (2019-2030)
3.7.3 Latin America Inhaler Devices for Respiratory Medicines Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Inhaler Devices for Respiratory Medicines Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhaler Devices for Respiratory Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Inhaler Devices for Respiratory Medicines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhaler Devices for Respiratory Medicines Sales by Type (2019-2030)
4.1.1 Global Inhaler Devices for Respiratory Medicines Sales by Type (2019-2024)
4.1.2 Global Inhaler Devices for Respiratory Medicines Sales by Type (2025-2030)
4.1.3 Global Inhaler Devices for Respiratory Medicines Sales Market Share by Type (2019-2030)
4.2 Global Inhaler Devices for Respiratory Medicines Revenue by Type (2019-2030)
4.2.1 Global Inhaler Devices for Respiratory Medicines Revenue by Type (2019-2024)
4.2.2 Global Inhaler Devices for Respiratory Medicines Revenue by Type (2025-2030)
4.2.3 Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Type (2019-2030)
4.3 Global Inhaler Devices for Respiratory Medicines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Inhaler Devices for Respiratory Medicines Sales by Application (2019-2030)
5.1.1 Global Inhaler Devices for Respiratory Medicines Sales by Application (2019-2024)
5.1.2 Global Inhaler Devices for Respiratory Medicines Sales by Application (2025-2030)
5.1.3 Global Inhaler Devices for Respiratory Medicines Sales Market Share by Application (2019-2030)
5.2 Global Inhaler Devices for Respiratory Medicines Revenue by Application (2019-2030)
5.2.1 Global Inhaler Devices for Respiratory Medicines Revenue by Application (2019-2024)
5.2.2 Global Inhaler Devices for Respiratory Medicines Revenue by Application (2025-2030)
5.2.3 Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Application (2019-2030)
5.3 Global Inhaler Devices for Respiratory Medicines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline (GSK)
6.1.1 GlaxoSmithKline (GSK) Company Information
6.1.2 GlaxoSmithKline (GSK) Description and Business Overview
6.1.3 GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Product Portfolio
6.1.5 GlaxoSmithKline (GSK) Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Inhaler Devices for Respiratory Medicines Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Company Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Inhaler Devices for Respiratory Medicines Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Viatris
6.5.1 Viatris Company Information
6.5.2 Viatris Description and Business Overview
6.5.3 Viatris Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Viatris Inhaler Devices for Respiratory Medicines Product Portfolio
6.5.5 Viatris Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Inhaler Devices for Respiratory Medicines Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 AptarGroup
6.7.1 AptarGroup Company Information
6.7.2 AptarGroup Description and Business Overview
6.7.3 AptarGroup Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.7.4 AptarGroup Inhaler Devices for Respiratory Medicines Product Portfolio
6.7.5 AptarGroup Recent Developments/Updates
6.8 Chiesi Farmaceutici
6.8.1 Chiesi Farmaceutici Company Information
6.8.2 Chiesi Farmaceutici Description and Business Overview
6.8.3 Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Product Portfolio
6.8.5 Chiesi Farmaceutici Recent Developments/Updates
6.9 Koninklijke Philips
6.9.1 Koninklijke Philips Company Information
6.9.2 Koninklijke Philips Description and Business Overview
6.9.3 Koninklijke Philips Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Koninklijke Philips Inhaler Devices for Respiratory Medicines Product Portfolio
6.9.5 Koninklijke Philips Recent Developments/Updates
6.10 Teva Pharmaceutical Industries
6.10.1 Teva Pharmaceutical Industries Company Information
6.10.2 Teva Pharmaceutical Industries Description and Business Overview
6.10.3 Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Product Portfolio
6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.11 Monaghan Medical
6.11.1 Monaghan Medical Company Information
6.11.2 Monaghan Medical Description and Business Overview
6.11.3 Monaghan Medical Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Monaghan Medical Inhaler Devices for Respiratory Medicines Product Portfolio
6.11.5 Monaghan Medical Recent Developments/Updates
6.12 OMRON
6.12.1 OMRON Company Information
6.12.2 OMRON Description and Business Overview
6.12.3 OMRON Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 OMRON Inhaler Devices for Respiratory Medicines Product Portfolio
6.12.5 OMRON Recent Developments/Updates
6.13 PARI International
6.13.1 PARI International Company Information
6.13.2 PARI International Description and Business Overview
6.13.3 PARI International Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 PARI International Inhaler Devices for Respiratory Medicines Product Portfolio
6.13.5 PARI International Recent Developments/Updates
6.14 Vectura
6.14.1 Vectura Company Information
6.14.2 Vectura Description and Business Overview
6.14.3 Vectura Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Vectura Inhaler Devices for Respiratory Medicines Product Portfolio
6.14.5 Vectura Recent Developments/Updates
6.15 H&T Presspart
6.15.1 H&T Presspart Company Information
6.15.2 H&T Presspart Description and Business Overview
6.15.3 H&T Presspart Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 H&T Presspart Inhaler Devices for Respiratory Medicines Product Portfolio
6.15.5 H&T Presspart Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhaler Devices for Respiratory Medicines Industry Chain Analysis
7.2 Inhaler Devices for Respiratory Medicines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhaler Devices for Respiratory Medicines Production Mode & Process
7.4 Inhaler Devices for Respiratory Medicines Sales and Marketing
7.4.1 Inhaler Devices for Respiratory Medicines Sales Channels
7.4.2 Inhaler Devices for Respiratory Medicines Distributors
7.5 Inhaler Devices for Respiratory Medicines Customers
8 Inhaler Devices for Respiratory Medicines Market Dynamics
8.1 Inhaler Devices for Respiratory Medicines Industry Trends
8.2 Inhaler Devices for Respiratory Medicines Market Drivers
8.3 Inhaler Devices for Respiratory Medicines Market Challenges
8.4 Inhaler Devices for Respiratory Medicines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Inhaler Devices for Respiratory Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Inhaler Devices for Respiratory Medicines Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Inhaler Devices for Respiratory Medicines Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Inhaler Devices for Respiratory Medicines Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Inhaler Devices for Respiratory Medicines Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Inhaler Devices for Respiratory Medicines Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Inhaler Devices for Respiratory Medicines Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Inhaler Devices for Respiratory Medicines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Inhaler Devices for Respiratory Medicines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Inhaler Devices for Respiratory Medicines, Product Type & Application
 Table 12. Global Key Manufacturers of Inhaler Devices for Respiratory Medicines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Inhaler Devices for Respiratory Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaler Devices for Respiratory Medicines as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Inhaler Devices for Respiratory Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Inhaler Devices for Respiratory Medicines Sales by Region (2019-2024) & (K Units)
 Table 18. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Region (2019-2024)
 Table 19. Global Inhaler Devices for Respiratory Medicines Sales by Region (2025-2030) & (K Units)
 Table 20. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Region (2025-2030)
 Table 21. Global Inhaler Devices for Respiratory Medicines Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Region (2019-2024)
 Table 23. Global Inhaler Devices for Respiratory Medicines Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Region (2025-2030)
 Table 25. North America Inhaler Devices for Respiratory Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Inhaler Devices for Respiratory Medicines Sales by Country (2019-2024) & (K Units)
 Table 27. North America Inhaler Devices for Respiratory Medicines Sales by Country (2025-2030) & (K Units)
 Table 28. North America Inhaler Devices for Respiratory Medicines Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Inhaler Devices for Respiratory Medicines Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Inhaler Devices for Respiratory Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Inhaler Devices for Respiratory Medicines Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Inhaler Devices for Respiratory Medicines Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Inhaler Devices for Respiratory Medicines Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Inhaler Devices for Respiratory Medicines Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Inhaler Devices for Respiratory Medicines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Inhaler Devices for Respiratory Medicines Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Inhaler Devices for Respiratory Medicines Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Inhaler Devices for Respiratory Medicines Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Inhaler Devices for Respiratory Medicines Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Inhaler Devices for Respiratory Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Inhaler Devices for Respiratory Medicines Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Inhaler Devices for Respiratory Medicines Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Inhaler Devices for Respiratory Medicines Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Inhaler Devices for Respiratory Medicines Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Inhaler Devices for Respiratory Medicines Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Inhaler Devices for Respiratory Medicines Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Inhaler Devices for Respiratory Medicines Sales (K Units) by Type (2019-2024)
 Table 51. Global Inhaler Devices for Respiratory Medicines Sales (K Units) by Type (2025-2030)
 Table 52. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Type (2019-2024)
 Table 53. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Type (2025-2030)
 Table 54. Global Inhaler Devices for Respiratory Medicines Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Inhaler Devices for Respiratory Medicines Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Type (2019-2024)
 Table 57. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Type (2025-2030)
 Table 58. Global Inhaler Devices for Respiratory Medicines Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Inhaler Devices for Respiratory Medicines Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Inhaler Devices for Respiratory Medicines Sales (K Units) by Application (2019-2024)
 Table 61. Global Inhaler Devices for Respiratory Medicines Sales (K Units) by Application (2025-2030)
 Table 62. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Application (2019-2024)
 Table 63. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Application (2025-2030)
 Table 64. Global Inhaler Devices for Respiratory Medicines Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Inhaler Devices for Respiratory Medicines Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Application (2019-2024)
 Table 67. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Application (2025-2030)
 Table 68. Global Inhaler Devices for Respiratory Medicines Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Inhaler Devices for Respiratory Medicines Price (US$/Unit) by Application (2025-2030)
 Table 70. GlaxoSmithKline (GSK) Company Information
 Table 71. GlaxoSmithKline (GSK) Description and Business Overview
 Table 72. GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Product
 Table 74. GlaxoSmithKline (GSK) Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. AstraZeneca Inhaler Devices for Respiratory Medicines Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Mylan Company Information
 Table 86. Mylan Description and Business Overview
 Table 87. Mylan Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Mylan Inhaler Devices for Respiratory Medicines Product
 Table 89. Mylan Recent Developments/Updates
 Table 90. Viatris Company Information
 Table 91. Viatris Description and Business Overview
 Table 92. Viatris Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Viatris Inhaler Devices for Respiratory Medicines Product
 Table 94. Viatris Recent Developments/Updates
 Table 95. Novartis Company Information
 Table 96. Novartis Description and Business Overview
 Table 97. Novartis Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Novartis Inhaler Devices for Respiratory Medicines Product
 Table 99. Novartis Recent Developments/Updates
 Table 100. AptarGroup Company Information
 Table 101. AptarGroup Description and Business Overview
 Table 102. AptarGroup Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. AptarGroup Inhaler Devices for Respiratory Medicines Product
 Table 104. AptarGroup Recent Developments/Updates
 Table 105. Chiesi Farmaceutici Company Information
 Table 106. Chiesi Farmaceutici Description and Business Overview
 Table 107. Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Product
 Table 109. Chiesi Farmaceutici Recent Developments/Updates
 Table 110. Koninklijke Philips Company Information
 Table 111. Koninklijke Philips Description and Business Overview
 Table 112. Koninklijke Philips Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Koninklijke Philips Inhaler Devices for Respiratory Medicines Product
 Table 114. Koninklijke Philips Recent Developments/Updates
 Table 115. Teva Pharmaceutical Industries Company Information
 Table 116. Teva Pharmaceutical Industries Description and Business Overview
 Table 117. Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Product
 Table 119. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 120. Monaghan Medical Company Information
 Table 121. Monaghan Medical Description and Business Overview
 Table 122. Monaghan Medical Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Monaghan Medical Inhaler Devices for Respiratory Medicines Product
 Table 124. Monaghan Medical Recent Developments/Updates
 Table 125. OMRON Company Information
 Table 126. OMRON Description and Business Overview
 Table 127. OMRON Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. OMRON Inhaler Devices for Respiratory Medicines Product
 Table 129. OMRON Recent Developments/Updates
 Table 130. PARI International Company Information
 Table 131. PARI International Description and Business Overview
 Table 132. PARI International Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. PARI International Inhaler Devices for Respiratory Medicines Product
 Table 134. PARI International Recent Developments/Updates
 Table 135. Vectura Company Information
 Table 136. Vectura Description and Business Overview
 Table 137. Vectura Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Vectura Inhaler Devices for Respiratory Medicines Product
 Table 139. Vectura Recent Developments/Updates
 Table 140. H&T Presspart Company Information
 Table 141. H&T Presspart Description and Business Overview
 Table 142. H&T Presspart Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. H&T Presspart Inhaler Devices for Respiratory Medicines Product
 Table 144. H&T Presspart Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Inhaler Devices for Respiratory Medicines Distributors List
 Table 148. Inhaler Devices for Respiratory Medicines Customers List
 Table 149. Inhaler Devices for Respiratory Medicines Market Trends
 Table 150. Inhaler Devices for Respiratory Medicines Market Drivers
 Table 151. Inhaler Devices for Respiratory Medicines Market Challenges
 Table 152. Inhaler Devices for Respiratory Medicines Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Inhaler Devices for Respiratory Medicines
 Figure 2. Global Inhaler Devices for Respiratory Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Inhaler Devices for Respiratory Medicines Market Share by Type: 2023 & 2030
 Figure 4. Metered- dose Inhalers Product Picture
 Figure 5. Dry-powder Inhalers Product Picture
 Figure 6. Nebulizers Product Picture
 Figure 7. Global Inhaler Devices for Respiratory Medicines Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Inhaler Devices for Respiratory Medicines Market Share by Application: 2023 & 2030
 Figure 9. Asthma
 Figure 10. Chronic Obstructive Pulmonary Disease (COPD)
 Figure 11. Cystic Fibrosis (CF)
 Figure 12. Idiopathic Pulmonary Fibrosis (IPF)
 Figure 13. Others
 Figure 14. Global Inhaler Devices for Respiratory Medicines Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Inhaler Devices for Respiratory Medicines Market Size (2019-2030) & (US$ Million)
 Figure 16. Global Inhaler Devices for Respiratory Medicines Sales (2019-2030) & (K Units)
 Figure 17. Global Inhaler Devices for Respiratory Medicines Average Price (US$/Unit) & (2019-2030)
 Figure 18. Inhaler Devices for Respiratory Medicines Report Years Considered
 Figure 19. Inhaler Devices for Respiratory Medicines Sales Share by Manufacturers in 2023
 Figure 20. Global Inhaler Devices for Respiratory Medicines Revenue Share by Manufacturers in 2023
 Figure 21. Global 5 and 10 Largest Inhaler Devices for Respiratory Medicines Players: Market Share by Revenue in Inhaler Devices for Respiratory Medicines in 2023
 Figure 22. Inhaler Devices for Respiratory Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 23. Global Inhaler Devices for Respiratory Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 24. North America Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2019-2030)
 Figure 25. North America Inhaler Devices for Respiratory Medicines Revenue Market Share by Country (2019-2030)
 Figure 26. United States Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Canada Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Europe Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2019-2030)
 Figure 29. Europe Inhaler Devices for Respiratory Medicines Revenue Market Share by Country (2019-2030)
 Figure 30. Germany Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. France Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. U.K. Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Italy Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Russia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Asia Pacific Inhaler Devices for Respiratory Medicines Sales Market Share by Region (2019-2030)
 Figure 36. Asia Pacific Inhaler Devices for Respiratory Medicines Revenue Market Share by Region (2019-2030)
 Figure 37. China Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Japan Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. South Korea Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. India Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Australia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Taiwan Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Latin America Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2019-2030)
 Figure 45. Mexico Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Brazil Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Argentina Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Colombia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Middle East and Africa Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2019-2030)
 Figure 50. Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue Market Share by Country (2019-2030)
 Figure 51. Turkey Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. UAE Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Global Sales Market Share of Inhaler Devices for Respiratory Medicines by Type (2019-2030)
 Figure 55. Global Revenue Market Share of Inhaler Devices for Respiratory Medicines by Type (2019-2030)
 Figure 56. Global Inhaler Devices for Respiratory Medicines Price (US$/Unit) by Type (2019-2030)
 Figure 57. Global Sales Market Share of Inhaler Devices for Respiratory Medicines by Application (2019-2030)
 Figure 58. Global Revenue Market Share of Inhaler Devices for Respiratory Medicines by Application (2019-2030)
 Figure 59. Global Inhaler Devices for Respiratory Medicines Price (US$/Unit) by Application (2019-2030)
 Figure 60. Inhaler Devices for Respiratory Medicines Value Chain
 Figure 61. Inhaler Devices for Respiratory Medicines Production Process
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Inhaled Treatment for Asthma and COPD Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Y19888
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Oxygen Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11D3386
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Chronic Obstructive Pulmonary Disorder (COPD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D2937
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Bronchiectasis Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18E6080
Mon Sep 08 00:00:00 UTC 2025

Add to Cart